Skip to main content
. 2019 Mar 25;15(4):51. doi: 10.1007/s11306-019-1511-8

Table 1.

List of metabolites with significant changes in the experimental treatments (p ≤ 0.01)

Compound Ambient Elevated [CO2] Elevated Temperature Combination
Log2(x̃) ± SE Log2(x̃) ± SE Log2(FC) Log2(x̃) ± SE Log2(FC) Log2(x̃) ± SE Log2(FC)
1,3-Diaminopropane 9.21 ± 0.27 9.81 ± 0.23 0.60 10.91 ± 0.13 1.70 9.95 ± 0.24 0.75
1-Benzylglucopyranoside 9.61 ± 0.21 10.56 ± 0.17 0.95 10.89 ± 0.26 1.28 10.76 ± 0.15 1.15
2-Methylmalic acid 11.27 ± 0.48 8.25 ± 0.17 − 3.02 9.60 ± 0.17 − 1.67 10.30 ± 0.38 − 0.97
α-ketoglutaric acid 9.93 ± 0.33 7.78 ± 0.21 − 2.15 10.57 ± 0.25 0.63 9.21 ± 0.25 − 0.72
α-tocopherol 10.85 ± 0.23 11.44 ± 0.23 0.59 12.25 ± 0.30 1.41 12.43 ± 0.16 1.58
γ-tocopherol 8.48 ± 0.17 8.90 ± 0.14 0.42 9.12 ± 0.18 0.64 8.26 ± 0.12 − 0.22
Arabinose 12.68 ± 0.12 13.21 ± 0.17 0.52 13.92 ± 0.25 1.24 13.34 ± 0.25 0.65
Arabitol 10.90 ± 0.22 11.61 ± 0.26* 0.71 11.67 ± 0.14 0.77 11.02 ± 0.16 0.12
Dehydroascorbic acid 11.54 ± 0.21 11.81 ± 0.14 0.27 12.57 ± 0.15 1.02 11.71 ± 0.19 0.17
Ethanolamine 14.58 ± 0.15 15.07 ± 0.13* 0.49 15.23 ± 0.11 0.65 14.70 ± 0.16 0.12
Fructose 20.19 ± 0.19 20.57 ± 0.21 0.38 21.27 ± 0.11 1.08 20.38 ± 0.23 0.19
Galactose 15.85 ± 0.18 16.71 ± 0.21 0.87 16.88 ± 0.18 1.03 16.22 ± 0.20 0.37
Gluconic acid 10.03 ± 0.05 10.68 ± 0.23 0.65 10.98 ± 0.17 0.95 10.77 ± 0.20 0.74
Glucose 20.55 ± 0.08 21.10 ± 0.21* 0.55 21.47 ± 0.09 0.92 20.54 ± 0.23 − 0.01
Glyceric acid 16.47 ± 0.12 17.20 ± 0.09 0.72 17.25 ± 0.15 0.78 16.54 ± 0.20 0.07
Inositol 14.78 ± 0.18 15.50 ± 0.19 0.71 15.83 ± 0.15 1.05 15.47 ± 0.16 0.68
Isoleucine 9.59 ± 0.17 10.40 ± 0.25 0.81 10.75 ± 0.22 1.16 10.58 ± 0.25 0.98
Leucine 9.45 ± 0.33 10.11 ± 0.11 0.66 10.95 ± 0.39 1.50 10.44 ± 0.35 0.98
Maltose 15.06 ± 0.15 15.50 ± 0.14 0.44 15.74 ± 0.07 0.68 14.98 ± 0.26 − 0.08
Melibiose 11.08 ± 0.23 11.91 ± 0.19 0.84 13.02 ± 0.27 1.94 12.24 ± 0.37 1.17
Neochlorogenic acid 16.72 ± 0.21 16.96 ± 0.11 0.24 17.32 ± 0.14 0.60 17.17 ± 0.13 0.45
O-acetylsalicylic acid 10.73 ± 0.11 11.00 ± 0.12 0.27 11.79 ± 0.19 1.06 11.09 ± 0.22 0.36
Oxalic acid 13.46 ± 0.16 13.54 ± 0.15 0.08 11.92 ± 0.31 − 1.54 12.04 ± 0.31 − 1.42
Phenylalanine 9.49 ± 0.13 9.83 ± 0.21 0.34 10.76 ± 0.36 1.27 10.81 ± 0.40 1.31
Quinic acid 17.30 ± 0.22 18.22 ± 0.12 0.92 18.14 ± 0.12 0.84 17.68 ± 0.13 0.39
Ribitiol 10.25 ± 0.25 10.81 ± 0.17 0.55 11.57 ± 0.21 1.32 10.90 ± 0.22* 0.64
Ribose 14.92 ± 0.17 15.25 ± 0.10 0.33 15.56 ± 0.12 0.64 15.13 ± 0.18 0.21
Serine 14.04 ± 0.11 13.92 ± 0.11 − 0.12 15.15 ± 0.16 1.11 14.36 ± 0.26 0.32
Sinapic acid 7.30 ± 0.19 7.74 ± 0.15 0.45 7.99 ± 0.20 0.69 7.98 ± 0.18 0.69
Stigmasterol 11.52 ± 0.14 12.14 ± 0.25 0.62 12.75 ± 0.22 1.23 12.65 ± 0.15* 1.13
Threitol 8.97 ± 0.12 9.28 ± 0.09 0.31 10.23 ± 0.15 1.26 9.78 ± 0.16 0.81
Threonine 11.90 ± 0.29 12.38 ± 0.11 0.46 13.30 ± 0.12 1.38 12.77 ± 0.26 0.85
Valine 10.57 ± 0.40 11.19 ± 0.15* 0.61 12.22 ± 0.18 1.64 11.91 ± 0.26 1.34
Xylose 8.80 ± 0.20 9.71 ± 0.15* 0.91 10.26 ± 0.26 1.46 10.08 ± 0.26 1.27

The log2 normalized median values ± standard error and log2fold change (log2(FC)) for each treatment are shown. Metabolites significantly changed are denoted by bold value (p ≤ 0.01) or *(p ≤ 0.05). Bold italic cells show increased metabolite content and italics represents decreased metabolite content in the treatments